Trial record 10 of 12 for:    allostim

An Individualized Anti-Cancer Vaccine in Advanced Hepatocellular Carcinoma Subjects

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT02409524
Recruitment Status : Recruiting
First Posted : April 7, 2015
Last Update Posted : July 12, 2016
Information provided by (Responsible Party):
Immunovative Therapies, Ltd.

No Study Results Posted on for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : July 2017
  Estimated Study Completion Date : August 2018